RIGVIR HOLDING
Rigvir Holding is the manufacturer of unique cancer medicine, which is able to find and destroy malignant tumor cells in the human body. This kind of cancer treatment, called oncolytic virotherapy, is evidence based and recognized as safe and effective therapy. Rigvir holding unites a group of companies whose activities are focused on production and development of oncolytic virotherapy cancer medicine.
RIGVIR HOLDING
Industry:
Health Care Medical Pharmaceutical
Founded:
2003-01-01
Address:
Riga, Riga, Latvia
Country:
Latvia
Website Url:
http://www.rigvir.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50 K EUR
Technology used in webpage:
20 To 29 CcTLD Redirects
Similar Organizations
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
SelfDiagnostics
Selfdiagnostics is an Estonian/German company with the purpose of developing and marketing medical point-of-care (POC) diagnostics devices.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Rigvir Holding
Official Site Inspections
http://www.rigvir.com Semrush global rank: 8.79 M Semrush visits lastest month: 257
- Host name: sl286.web.hostpoint.ch
- IP address: 217.26.55.112
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
